Skip to main content
Top
Published in: International Journal of Hematology 2/2010

01-09-2010 | Original Article

The association of protein S Tokushima-K196E with a risk of deep vein thrombosis

Authors: Makoto Ikejiri, Hideo Wada, Yuko Sakamoto, Naohiko Ito, Junji Nishioka, Kaname Nakatani, Akihiro Tsuji, Norikazu Yamada, Mashio Nakamura, Masaaki Ito, Tsutomu Nobori

Published in: International Journal of Hematology | Issue 2/2010

Login to get access

Abstract

Deep vein thrombosis (DVT) is a multifactorial disease caused by acquired risk factors such as a bed rest, surgery and malignancies. Although the factor V Leiden and the prothrombin-20210G>A mutation do not exist in Japanese populations, a mutation in protein S (PS) Tokushima (K196E) has been attracting attention in Japan. In this study, the genetic contribution of PS Tokushima (K196E) was evaluated in 60 Japanese patients with thrombosis in comparison to 234 healthy volunteers and 88 patients without thrombosis. Genes associated with the response to warfarin, cytochrome P450 2C9 (CYP2C9), vitamin K epoxide reductase complex subunit 1 (VKORC1), and γ-glutamyl carboxylase (GGCX) were also investigated simultaneously. PS Tokushima (K196E) was detected in 6 patients with thrombosis, in 3 without thrombosis and in 3 healthy volunteers, indicating that there is a high frequency of the PS Tokushima (K196E). There were no significant differences of CYP2C9, VKORC1 or GGCX between the patients with and without DVT. Therefore, PS Tokushima (K196E) is an important genetic risk factor for DVT in the Japanese population.
Literature
1.
go back to reference Dahlbäck B. The protein C anticoagulant system: inherited defects as basis for venous thrombosis. Thromb Res. 1995;77:1–43.CrossRefPubMed Dahlbäck B. The protein C anticoagulant system: inherited defects as basis for venous thrombosis. Thromb Res. 1995;77:1–43.CrossRefPubMed
2.
go back to reference Dahlbäck B. Protein S and C4b-binding protein: components involved n the regulation of the protein C anticoagulant system. Thromb Haemost. 1991;66:49–61.PubMed Dahlbäck B. Protein S and C4b-binding protein: components involved n the regulation of the protein C anticoagulant system. Thromb Haemost. 1991;66:49–61.PubMed
3.
go back to reference Makris M, Leach M, Beauchamp NJ, Daly ME, Cooper PC, Hampton KK, et al. Gene analysis, phenotypic diagnosis, and risk of venous thrombosis in families with inherited deficiencies of protein S. Blood. 2000;95:1935–44.PubMed Makris M, Leach M, Beauchamp NJ, Daly ME, Cooper PC, Hampton KK, et al. Gene analysis, phenotypic diagnosis, and risk of venous thrombosis in families with inherited deficiencies of protein S. Blood. 2000;95:1935–44.PubMed
4.
go back to reference Beauchamp NJ, Dykes AC, Parikh N, Campbell Tait R, Daly ME. The prevalence of, and molecular defects underlying, inherited protein S deficiency in the general population. Br J Haematol. 2004;125:647–54.CrossRefPubMed Beauchamp NJ, Dykes AC, Parikh N, Campbell Tait R, Daly ME. The prevalence of, and molecular defects underlying, inherited protein S deficiency in the general population. Br J Haematol. 2004;125:647–54.CrossRefPubMed
5.
go back to reference Sakata T, Okamoto A, Mannami T, Tomoike H, Miyata T. Prevalence of protein S deficiency in the Japanese general population: the Suita Study. J Thromb Haemost. 2004;2:1012–3.CrossRefPubMed Sakata T, Okamoto A, Mannami T, Tomoike H, Miyata T. Prevalence of protein S deficiency in the Japanese general population: the Suita Study. J Thromb Haemost. 2004;2:1012–3.CrossRefPubMed
6.
go back to reference Nomura T, Suehisa E, Kawasaki T, Okada A. Frequency of protein S deficiency in general Japanese population. Thromb Res. 2000;100:367–71.CrossRefPubMed Nomura T, Suehisa E, Kawasaki T, Okada A. Frequency of protein S deficiency in general Japanese population. Thromb Res. 2000;100:367–71.CrossRefPubMed
7.
go back to reference Tsuda H, Hattori S, Tanabe S, Iida H, Nakahara M, Nishioka S, et al. Screening for aetiology of thrombophilia: a high prevalence of protein S abnormality. Ann Clin Biochem. 1999;36:423–32.PubMed Tsuda H, Hattori S, Tanabe S, Iida H, Nakahara M, Nishioka S, et al. Screening for aetiology of thrombophilia: a high prevalence of protein S abnormality. Ann Clin Biochem. 1999;36:423–32.PubMed
8.
go back to reference Hamasaki N, Kanaji T. Clinical role of protein S deficiency in Asian population. In: Tanaka K, Davie EW, editors. Recent advance in thrombosis and hemostasis. Japan: Springer; 2008. p. 597–613.CrossRef Hamasaki N, Kanaji T. Clinical role of protein S deficiency in Asian population. In: Tanaka K, Davie EW, editors. Recent advance in thrombosis and hemostasis. Japan: Springer; 2008. p. 597–613.CrossRef
9.
go back to reference Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsma PH. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature. 1994;369:64–7.CrossRefPubMed Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsma PH. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature. 1994;369:64–7.CrossRefPubMed
10.
go back to reference Ridker PM, Hennekens CH, Lindpaintner K, Stampfer MJ, Eisenberg PR, Miletich JP. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. N Engl J Med. 1995;332:912–7.CrossRefPubMed Ridker PM, Hennekens CH, Lindpaintner K, Stampfer MJ, Eisenberg PR, Miletich JP. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. N Engl J Med. 1995;332:912–7.CrossRefPubMed
11.
go back to reference Kinoshita S, Iida H, Inoue S, Watanabe K, Kurihara M, Wada Y, et al. Protein S and protein C gene mutations in Japanese deep vein thrombosis patient. Clin Biochem. 2005;38:908–15.CrossRefPubMed Kinoshita S, Iida H, Inoue S, Watanabe K, Kurihara M, Wada Y, et al. Protein S and protein C gene mutations in Japanese deep vein thrombosis patient. Clin Biochem. 2005;38:908–15.CrossRefPubMed
12.
go back to reference Gandrille S, Borgel D, Sala N, Espinosa-Parrilla Y, Simmonds R, Rezende S, et al. Protein S deficiency; a database of mutations—summary of the first update. Thromb Haemost. 2000;84:918.PubMed Gandrille S, Borgel D, Sala N, Espinosa-Parrilla Y, Simmonds R, Rezende S, et al. Protein S deficiency; a database of mutations—summary of the first update. Thromb Haemost. 2000;84:918.PubMed
13.
go back to reference Hayashi T, Nishioka J, Shigekiyo T, Saito S, Suzuki K. Protein S Tokushima: abnormal molecule with a substitution of Glu for Lys-155 in the second epidermal growth factor-like domain of protein S. Blood. 1994;83:683–90.PubMed Hayashi T, Nishioka J, Shigekiyo T, Saito S, Suzuki K. Protein S Tokushima: abnormal molecule with a substitution of Glu for Lys-155 in the second epidermal growth factor-like domain of protein S. Blood. 1994;83:683–90.PubMed
14.
go back to reference Hayashi T, Nishioka J, Suzuki K. Molecular mechanism of the dysfunction of protein S (Tokushima) (Lys155→Glu) for the regulation of the blood coagulation system. Biochim Biophys Acta. 1995;1272:159–67.PubMed Hayashi T, Nishioka J, Suzuki K. Molecular mechanism of the dysfunction of protein S (Tokushima) (Lys155→Glu) for the regulation of the blood coagulation system. Biochim Biophys Acta. 1995;1272:159–67.PubMed
15.
go back to reference Kimura R, Honda S, Kawasaki T, Tsuji H, Madoiwa S, Sakata Y, et al. Protein S-K196E mutation as a genetic risk factor for deep vein thrombosis in Japanese patients. Blood. 2006;107:1737–8.CrossRefPubMed Kimura R, Honda S, Kawasaki T, Tsuji H, Madoiwa S, Sakata Y, et al. Protein S-K196E mutation as a genetic risk factor for deep vein thrombosis in Japanese patients. Blood. 2006;107:1737–8.CrossRefPubMed
16.
go back to reference Mushiroda T, Ohnishi Y, Saito S, Takahashi A, Kikuchi Y, Saito S, et al. Association of VKORC1 and CYP2C9 polymorphisms with warfarin dose requirements in Japanese patients. J Hum Genet. 2006;51:249–53.CrossRefPubMed Mushiroda T, Ohnishi Y, Saito S, Takahashi A, Kikuchi Y, Saito S, et al. Association of VKORC1 and CYP2C9 polymorphisms with warfarin dose requirements in Japanese patients. J Hum Genet. 2006;51:249–53.CrossRefPubMed
17.
go back to reference Takahashi H, Wilkinson GR, Nutescu EA, Morita T, Ritchie MD, Scordo MG, et al. Different contributions of polymorphisms in VKORC1 and CYP2C9 to intra- and inter-population differences in maintenance dose of warfarin in Japanese, Caucasians and African-Americans. Pharmacogenet Genomics. 2006;16:101–10.CrossRefPubMed Takahashi H, Wilkinson GR, Nutescu EA, Morita T, Ritchie MD, Scordo MG, et al. Different contributions of polymorphisms in VKORC1 and CYP2C9 to intra- and inter-population differences in maintenance dose of warfarin in Japanese, Caucasians and African-Americans. Pharmacogenet Genomics. 2006;16:101–10.CrossRefPubMed
18.
go back to reference Kimura R, Miyashita K, Kokubo Y, Akaiwa Y, Otsubo R, Nagatsuka K, et al. Genotypes of vitamin K epoxide reductase, gamma-glutamyl carboxylase, and cytochrome P450 2C9 as determinants of daily warfarin dose in Japanese patients. Thromb Res. 2007;120(2):181–6.CrossRefPubMed Kimura R, Miyashita K, Kokubo Y, Akaiwa Y, Otsubo R, Nagatsuka K, et al. Genotypes of vitamin K epoxide reductase, gamma-glutamyl carboxylase, and cytochrome P450 2C9 as determinants of daily warfarin dose in Japanese patients. Thromb Res. 2007;120(2):181–6.CrossRefPubMed
19.
go back to reference Okada H, Takagi A, Adachi T, Yamamoto K, Matsushita T, Takamatsu J, et al. Identification of protein Sa gene mutations including four novel mutations in eight unrelated patients with protein S deficiency. Br J Haematol. 2004;126:219–25.CrossRefPubMed Okada H, Takagi A, Adachi T, Yamamoto K, Matsushita T, Takamatsu J, et al. Identification of protein Sa gene mutations including four novel mutations in eight unrelated patients with protein S deficiency. Br J Haematol. 2004;126:219–25.CrossRefPubMed
20.
go back to reference Suehisa E, Nomura T, Kawasaki T, Kanakura Y. Frequency of natural coagulation inhibitor (antithrombin III, protein C and protein S) deficiencies in Japanese patients with spontaneous deep vein thrombosis. Blood Coagul Fibrinolysis. 2001;12:95–9.CrossRefPubMed Suehisa E, Nomura T, Kawasaki T, Kanakura Y. Frequency of natural coagulation inhibitor (antithrombin III, protein C and protein S) deficiencies in Japanese patients with spontaneous deep vein thrombosis. Blood Coagul Fibrinolysis. 2001;12:95–9.CrossRefPubMed
Metadata
Title
The association of protein S Tokushima-K196E with a risk of deep vein thrombosis
Authors
Makoto Ikejiri
Hideo Wada
Yuko Sakamoto
Naohiko Ito
Junji Nishioka
Kaname Nakatani
Akihiro Tsuji
Norikazu Yamada
Mashio Nakamura
Masaaki Ito
Tsutomu Nobori
Publication date
01-09-2010
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 2/2010
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1007/s12185-010-0671-0

Other articles of this Issue 2/2010

International Journal of Hematology 2/2010 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine